The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS)· 2022 · 44 citations
2. GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats· 2014 · 65 citations
3. Suicide attempts after bariatric surgery: comparison to a nonsurgical cohort of individuals with severe obesity· 2023 · 16 citations
4. GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease· 2021 · 177 citations
5. GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans· 2021 · 40 citations